A good write up for sure.
“ICL will be granted sole manufacturing, marketing and sales rights to the Alexium NF product globally”
Surely they will negotiate a good decent upfront payment for these significant NF rights to be given away!? Much like a biotech would with big pharma and even get ICL to take a10% stake in the company as a way to raise some cash. Hopefully it won’t be too long before we finally see a decent licensing agreement. I recall a few years ago both GR and NC saying an agreement was imminent. Yeah right!
Ann: Appendix 4C - quarterly, page-45
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AJX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.46M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 42000 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 11400 | 1 |
View Market Depth
| Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
| AJX (ASX) Chart |
Day chart unavailable